EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Clinical Experience of Isolated Metachronous Adrenal Gland Metastases from Solid Primary Carcinomas

Min Jae Cho, Jae Won Cho, Yu-mi Lee, Tae-Yon Sung, Jong Ho Yoon, Ki-Wook Chung, Suck Joon Hong

Journal of Endocrine Surgery · 2017

DOI: 10.16956/jes.2017.17.2.73 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Endocrine Surgery, 2017. Verfasst von Min Jae Cho und 6 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Owing to the development of improved techniques, the use of adrenal gland surgery for the treatment of metachronous metastatic adrenal tumors originating from primary carcinomas has increased. Here, we have analyzed the postoperative outcomes of patients who received surgical treatment for isolated metastatic adrenal gland originated from solid primary carcinomas.

Methods

Patients who underwent metastatic adrenalectomy after treatment of the primary carcinoma at the Asan Medical Center from 2000 to 2010 were included. Clinicopathological parameters were analyzed to determine the prognostic outcomes.

Results

Our study cohort consisted of 21 patients with hepatocellular carcinoma (n=10), lung carcinoma (n=8), and colorectal carcinoma (n=3). The mean age was 54.6 years old. The mean overall survival (OS) duration was 78.5 months. Disease-specific recurrence-free survival (RFS) after metastatic adrenalectomy was significantly longer when the interval between primary carcinoma treatment and metachronous metastasis to the adrenal glands was ≥16 months (P=0.043). There was no significant difference in disease-specific RFS between patients who underwent open adrenalectomy (OA) vs. laparoscopic adrenalectomy (LA) (P=0.063).

Conclusion

Surgical treatment should be recommended for isolated metachronous adrenal gland metastases when the interval between primary carcinoma treatment and metastasis is ≥16 months to achieve better disease-specific RFS. LA was not inferior to OA.

Zitieren

APA

Cho, M. J., Cho, J. W., Lee, Y., Sung, T., Yoon, J. H., Chung, K., & Hong, S. J. (2017). Clinical Experience of Isolated Metachronous Adrenal Gland Metastases from Solid Primary Carcinomas. Journal of Endocrine Surgery. https://doi.org/10.16956/jes.2017.17.2.73

Vancouver

Cho MJ, Cho JW, Lee Y, Sung T, Yoon JH, Chung K, et al. Clinical Experience of Isolated Metachronous Adrenal Gland Metastases from Solid Primary Carcinomas. Journal of Endocrine Surgery. 2017. doi:10.16956/jes.2017.17.2.73

BibTeX
@article{Cho2017,
  author = {Cho, Min Jae and Cho, Jae Won and Lee, Yu-mi and Sung, Tae-Yon and Yoon, Jong Ho and Chung, Ki-Wook and Hong, Suck Joon},
  title = {Clinical Experience of Isolated Metachronous Adrenal Gland Metastases from Solid Primary Carcinomas},
  journal = {Journal of Endocrine Surgery},
  year = {2017},
  doi = {10.16956/jes.2017.17.2.73}
}
Kostenlos starten →